These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 28098662

  • 1. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: A Case Report.
    Samejima Y, Kodaka M, Ichikawa J, Mori T, Ando K, Nishiyama K, Komori M.
    A A Case Rep; 2017 Mar 01; 8(5):100-104. PubMed ID: 28098662
    [Abstract] [Full Text] [Related]

  • 2. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr 01; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 3. The Application of ROTEM in a Parturient With Antiphospholipid Syndrome in the Setting of Anticoagulation for Cesarean Delivery: A Case Report.
    Fiol AG, Fardelmann KL, McGuire PJ, Merriam AA, Miller A, Alian A.
    A A Pract; 2020 Apr 01; 14(6):e01182. PubMed ID: 32224689
    [Abstract] [Full Text] [Related]

  • 4. Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study.
    Gronchi F, Perret A, Ferrari E, Marcucci CM, Flèche J, Crosset M, Schoettker P, Marcucci C.
    Eur J Anaesthesiol; 2014 Feb 01; 31(2):68-75. PubMed ID: 23867776
    [Abstract] [Full Text] [Related]

  • 5. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T, Wolf HG, Sinzobahamvya N, Asfour B, Hraska V, Schindler E.
    Thorac Cardiovasc Surg; 2015 Aug 01; 63(5):397-403. PubMed ID: 26121380
    [Abstract] [Full Text] [Related]

  • 6. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG.
    J Thorac Cardiovasc Surg; 1995 Jul 01; 110(1):46-54. PubMed ID: 7609568
    [Abstract] [Full Text] [Related]

  • 7. [A successful perioperative anticoagulation therapy and monitoring of a patient with hereditary plasminogen abnormality undergoing aortic valve replacement].
    Miyashita T, Inagawa G, Noumi T, Tachibana K, Kuro M.
    Masui; 1998 Mar 01; 47(3):341-5. PubMed ID: 9560548
    [Abstract] [Full Text] [Related]

  • 8. Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome.
    Nakajima T, Enomoto Y, Ishigaki M, Hasegawa Y, Tokunaga C, Hiramatsu Y, Sakamoto H.
    J Card Surg; 2017 Oct 01; 32(10):633-635. PubMed ID: 28944492
    [Abstract] [Full Text] [Related]

  • 9. Aortic valve replacement and perioperative management in hemodialyzed patient wth antiphospholipid syndrome.
    Lango R, Pawlaczyk R, Raszeja-Specht A, Smoleński RT, Rogowski J, Rutkowski B, Szutowicz A.
    Int J Artif Organs; 2004 Jan 01; 27(1):69-73. PubMed ID: 14984186
    [Abstract] [Full Text] [Related]

  • 10. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar 01; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 11. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery.
    Ichikawa J, Kodaka M, Nishiyama K, Hirasaki Y, Ozaki M, Komori M.
    J Cardiothorac Vasc Anesth; 2014 Aug 01; 28(4):1003-7. PubMed ID: 24508375
    [Abstract] [Full Text] [Related]

  • 12. Severe antiphospholipid syndrome and cardiac surgery: Perioperative management.
    Mishra PK, Khazi FM, Yiu P, Billing JS.
    Asian Cardiovasc Thorac Ann; 2016 Jun 01; 24(5):473-6. PubMed ID: 25829458
    [Abstract] [Full Text] [Related]

  • 13. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
    Yamanishi H, Watanabe S, Hayashi K, Tomioka H, Minami M, Nozaki Y, Aoki T, Kawai Y, Kishino K, Ohta S.
    Kyobu Geka; 1997 Jun 01; 50(6):459-62. PubMed ID: 9185440
    [Abstract] [Full Text] [Related]

  • 14. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb 01; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 15. TEG improves anticoagulation management during cardiopulmonary bypass complicated by antiphospholipid syndrome.
    Nakajima T, Kato H, Mathis BJ, Hiramatsu Y, Sakamoto H.
    J Card Surg; 2020 Jun 01; 35(6):1354-1356. PubMed ID: 32302025
    [Abstract] [Full Text] [Related]

  • 16. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R, Babka R, Sullivan HJ, Montoya A, Bakhos M, El-Etr A.
    J Thorac Cardiovasc Surg; 1981 Mar 01; 81(3):378-81. PubMed ID: 7464201
    [Abstract] [Full Text] [Related]

  • 17. Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome.
    Seki T, Shingu Y, Sugiki H, Wakasa S, Katoh H, Ooka T, Tachibana T, Kubota S, Matsui Y.
    J Artif Organs; 2018 Sep 01; 21(3):363-366. PubMed ID: 29541945
    [Abstract] [Full Text] [Related]

  • 18. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
    Willems A, Savan V, Faraoni D, De Ville A, Rozen L, Demulder A, Van der Linden P.
    J Cardiothorac Vasc Anesth; 2016 Oct 01; 30(5):1184-9. PubMed ID: 27461795
    [Abstract] [Full Text] [Related]

  • 19. A Patient With Remote Heparin-Induced Thrombocytopenia and Antiphospholipid Syndrome Requiring Cardiopulmonary Bypass: Do Current Guidelines Apply?
    Ibrahim W, Nakia H, Stephen M, Bruce S, Bryan W, William P.
    Semin Cardiothorac Vasc Anesth; 2019 Jun 01; 23(2):256-260. PubMed ID: 29871549
    [Abstract] [Full Text] [Related]

  • 20. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul 01; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.